[Federal Register Volume 77, Number 203 (Friday, October 19, 2012)]
[Notices]
[Page 64347]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-25731]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Diabetes Mellitus Interagency Coordinating Committee 
Meeting

SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee 
(DMICC) will hold a meeting on November 15, 2012, from 9:00 to 11:30 
a.m. at the Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817. The meeting is open to the public.

DATES: The meeting will be held on November 15, 2012, from 9:00 to 
11:30 a.m. Individuals wanting to present oral comments must notify the 
contact person at least 10 days before the meeting date.

ADDRESSES: The meeting will be held at Bethesda Marriott Suites, 6711 
Democracy Boulevard, Bethesda, MD 20817.

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, see the DMICC Web site, www.diabetescommittee.gov, or 
contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes 
Mellitus Interagency Coordinating Committee, National Institute of 
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 
31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496-
6623; FAX: 301-480-6741; email: [email protected].

SUPPLEMENTARY INFORMATION: The DMICC, chaired by the National Institute 
of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising 
members of the Department of Health and Human Services and other 
federal agencies that support diabetes-related activities, facilitates 
cooperation, communication, and collaboration on diabetes among 
government entities. DMICC meetings, held several times a year, provide 
an opportunity for Committee members to learn about and discuss current 
and future diabetes programs in DMICC member organizations and to 
identify opportunities for collaboration. The November 15, 2012, DMICC 
meeting will focus on ``Federal Initiatives To Address Gestational 
Diabetes Mellitus.''
    Any member of the public interested in presenting oral comments to 
the Committee should notify the contact person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present; oral 
comments and presentations will be limited to a maximum of 5 minutes. 
Printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding their statement to the contact person listed on 
this notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person. Because of time constraints for the meeting, 
oral comments will be allowed on a first-come, first-serve basis.
    Members of the public who would like to receive email notification 
about future DMICC meetings should register for the listserv available 
on the DMICC Web site, www.diabetescommittee.gov.

    Dated: October 9, 2012.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy 
Analysis, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institutes of Health.
[FR Doc. 2012-25731 Filed 10-18-12; 8:45 am]
BILLING CODE 4140-01-P